46.4
Biofrontera Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
43.1
FY23:
23.1
FY24:
20.7
FY25:
18.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.80
FY22:
7.74
FY23:
4.86
FY24:
1.40
FY25:
10.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
53.2
FY22:
50.9
FY23:
27.9
FY24:
22.1
FY25:
28.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
13.8
FY22:
20.9
FY23:
18.1
FY24:
12.0
FY25:
11.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
28.0
FY22:
6.11
FY23:
5.05
FY24:
5.65
FY25:
6.19
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.3
FY22:
23.9
FY23:
4.79
FY24:
4.43
FY25:
10.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
53.2
FY22:
50.9
FY23:
27.9
FY24:
22.1
FY25:
28.6
All amounts in millions USD